Study Details
A study to see if an investigational study drug, nerandomilast, helps people with SARD-ILD
(IRB#: IRB_00190779)
The purpose of this study is to investigate whether a drug called nerandomilast works to help people with SARD-ILD improve their lung function. You will be in the study for about 7.5 months. During this time, you will visit the study site 8 times.
- All genders
- Over 18 years old
- Volunteers with special conditions
- In Person
- Paid
Who can participate?
Gender: All genders
Age: Over 18 years old
Volunteers: Volunteers with special conditions
Location: In Person
Inclusion Criteria
- 1. Participant has SARD-ILD
- 2. Patients 18 years old
Exclusion Criteria
- 1. Acute ILD exacerbation within 3 months prior to Visit 1
- 2. Patients with active TB
- 3. Patients with underlying liver cirrhosis
- 4. Women who are pregnant, breastfeeding, or who plan to become pregnant while in the trial
Will I be paid for my time?
Yes
IRB#: IRB_00190779
PI: Mary Beth Scholand
Department: PULMONARY
Approval Date: 2026-03-18 06:00:00
Specialties: Pulmonary
I am Interested